Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 6, 2000, Pages 591-599

  Thummel, Kenneth E ^a,b   Slattery, John T ^a,b   Ro, Howard ^a,b   Chien, Jenny Y ^a,b   Nelson, Sidney D ^a,b   Lown, Kenneth E ^a,b   Watkins, Paul B ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PARACETAMOL;

ALCOHOL METABOLISM; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG ALCOHOL INTERACTION; DRUG CLEARANCE; DRUG METABOLISM; DRUG OXIDATION; DRUG SAFETY; ENZYME MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; LIVER TOXICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034047262     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.106574     Document Type: Article

References (43)

1. 1. McClain C, Kromhout J, Peterson F, Holtzman J. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980;244:251-3.
2. 2. Seef L, Cuccherini B, Zimmerman H, Adler E, Benjamin S. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399-404.
3. 3. Zimmerman H, Maddrey W. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995;22:767-73.
4. 4. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-7.
5. 5. Girre C, Lucas D, Hispard E, Menez C, Sylvain D, Menez J. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994;47:1503-8.
6. 6. Lucas D, Menez C, Girre C, Bodenez P, Hispard E, Menez J. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res 1995; 19:362-6.
7. 7. Raucy J, Lasker J, Lieber C, Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989;271:270-83.
8. 8. Patten C, Thomas P, Guy R, Lee M, Gonzalez F, Guengerich F, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993;6:511-8.
9. 9. Thummel K, Lee C, Kunze K, Nelson S, Slattery J. Oxidation of acetaminophen to N-acetyl-p-aminoquinone imine by human CYP3A4. Biochem Pharmacol 1993;45: 1563-9.
10. 10. Sarich T, Kalhorn T, Magee S, Al-Sayegh F, Adams S, Slattery J, et al. The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin. Clin Pharmacol Ther 1997;62: 21-8.
11. 11. Nelson S. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990;10:267-78.
12. 12. Forrest J, Clements J, Prescott L. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982;7:93-107.
13. 13. Banda P, Quart B. The effect of mild alcohol consumption on the metabolism of acetaminophen in man. Res Commun Chem Pathol Pharmacol 1982;38:57-70.
14. 14. Critchley J, Dyson E, Scott A, Jarvie J, Prescott L. Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning? Lancet 1983:1:1375-6.
15. 15. Sato C, Nakano M, Lieber C. Prevention of acetaminophen-induced hepatotoxicity by acute ethanol administration in the rat: comparison with carbon tetrachloride-induced hepatotoxicity. J Pharmacol Exp Ther 1981;218:805-10.
16. 16. Altomare E, Leo M, Lieber C. Interaction of acute ethanol administration with acetaminophen metabolism and toxicity in rats fed alcohol chronically. Alcohol Clin Exp Res 1984;8:405-8.
17. 17. Lieber C. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997;77:517-44.
18. 18. Zand R, Slattery SD, Thummel KE, Kalhorn TF, Adams SP, Wright JM. Inhibition and induction of CYP2E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther 1993;54:142-9.
19. 19. Chien JY, Peter RM, Nolan CM, Wartell C, Slattery JT, Nelson SD, et al. Influence of NAT2 phenotype on the inhibition and induction of acetaminophen bioactivation with chronic isoniazid. Clin Pharmacol Ther 1996;61:24-34.
20. 20. Pantuck EJ, Pantuck CB, Ryan DE, Conney AH. Inhibition and stimulation of enfurane metabolism in the rat following a single dose or chronic administration of ethanol. Anesthesiology 1985;62:255-62.
21. 21. Epstein M, Nelson S, Slattery J, Kalhorn T, Wall R, Wright J. Inhibition of the metabolism of paracetamol by isoniazid. Br J Clin Pharmacol 1991;31:139-42.
22. 22. Chien JY, Thummel KE, Slattery JT. Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization. Drug Metab Dispos 1997;25:1165-75.
23. 23. Ekins B, Rollins D, Duffy D, Gregory M. Standardized treatment of severe methanol poisoning with ethanol and hemodialysis. West J Med 1985;142:337-40.
24. 24. Slattery J, Wilson J, Kalhorn T, Nelson S. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 1987;41:413-8.
25. 25. Eliasson E, Johansson I, Ingelman-Sundberg M. Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary hepatocyte cell cultures. Biochem Biophys Res Commun 1988;150:436-43.
26. 26. Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE. Ethanol induces CYP2E1 by protein stabilization: role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 1995;270:29632-5.
27. 27. Song BJ, Veech RL, Park SS, Gelboin HV, Gonzalez FJ. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J Biol Chem 1989;264:3568-72.
28. 28. Kostrubsky V, Strom S, Wood S, Wrighton S, Sinclair P, Sinclair J. Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch Biochem Biophys 1995;322:516-20.
29. 29. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450: studies in rats and patients. J Clin Invest 1989:83:688-97.
30. 30. Wilkinson P, Sedman A, Sakmar E, Earhart R, Weidler D, Wagner J. Blood ethanol concentrations during and following constant-rate intravenous infusion of alcohol. Clin Pharmacol Ther 1976;19:213-23.
31. 31. Linden C, Rumack B. Acetaminophen overdose. Emerg Med Clin North Am 1984;2:103-19.
32. 32. Kubota S, Lasker J, Lieber C. Molecular regulation of ethanol-inducible cytochrome P450-IIE1 in hamsters. Biochem Biophys Res Commun 1988;150:304-10.
33. 33. Ronis M, Huang J, Crouch J, Mercado C, Irby D, Valentine C, et al. Cytochrome P450 CYP2E1 induction during chronic alcohol exposure occurs by a two step mechanism associated with blood alcohol concentrations in rats. J Pharmacol Exp Ther 1993;264:944-64.
34. 34. Badger T, Ronis M, Ingelman-Sundberg M, Hakkak R. Pulsatile blood alcohol and CYP2E1 induction during chronic alcohol infusion in rats. Alcohol 1993;10:453-7.
35. 35. Tsutsumi M, Lasker J, Takahashi T, Lieber C. In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 1993;304:209-18.
36. 36. Tsutsumi M, Lasker J, Shimizu M, Rosman A, Lieber C. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989;10: 437-46.
37. 37. Takahashi T, Lasker J, Rosman A, Lieber C. Induction of cytochrome P-4502E1 in the human liver is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993;17:236-45.
38. 38. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernandez-Checa J. Hepatic mitochodrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992;16:1423-7.
39. 39. Garcia-Ruiz C, Morales A, Ballesta A, Rodes J, Kaplowitz N, Fernandez-Checa J. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994;94:193-201.
40. 40. Whitcomb D, Block G. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272:1845-50.
41. 41. O'Shea D, Davis S, Kim R, Wilkinson G. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 1994;56:359-67.
42. 42. Ludwig J, McGill D, Lindor K. Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997;12:398-403.
43. 43. Wallace J. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997;112:1000-16.